BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28408813)

  • 21. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
    Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study.
    de-Torres JP; Casanova C; Marín JM; Zagaceta J; Alcaide AB; Seijo LM; Campo A; Carrizo S; Montes U; Cordoba-Lanus E; Baz-Dávila R; Aguirre-Jaime A; Celli BR; Zulueta JJ
    Respir Med; 2013 May; 107(5):702-7. PubMed ID: 23465176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
    Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease.
    Ho SC; Wang JY; Kuo HP; Huang CD; Lee KY; Chuang HC; Feng PH; Chen TT; Hsu MF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2075-80. PubMed ID: 27621613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
    Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
    Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations.
    Ahn YH; Lee KS; Park JH; Jung JH; Lee M; Jung YJ; Chung WY; Sheen S; Park KJ; Kim DJ; Kang DR; Lee JD; Yoon S; Jin XJ; Yang HM; Lim HS; Park JS; Shin JH; Tahk SJ
    Respiration; 2015; 90(3):199-205. PubMed ID: 26278777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer: a nationwide study in Spain.
    Baré M; Montón C; Mora L; Redondo M; Pont M; Escobar A; Sarasqueta C; Fernández de Larrea N; Briones E; Quintana JM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1233-1241. PubMed ID: 28461746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.
    Lim J; Shin KM; Lee K; Lim JK; Kim HJ; Cho SH; Cha SI
    AJR Am J Roentgenol; 2015 Sep; 205(3):540-5. PubMed ID: 26295639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.
    Izquierdo JL; Resano P; El Hachem A; Graziani D; Almonacid C; Sánchez IM
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1053-8. PubMed ID: 25336937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease.
    Nilsson U; Blomberg A; Johansson B; Backman H; Eriksson B; Lindberg A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2507-2514. PubMed ID: 28860744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection.
    Sekine Y; Yamada Y; Chiyo M; Iwata T; Nakajima T; Yasufuku K; Suzuki M; Fujisawa T
    Ann Thorac Surg; 2007 Sep; 84(3):946-50. PubMed ID: 17720404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.